ATC Group: J01MA02 Ciprofloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01MA02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01M Quinolone antibacterials
4 J01MA Fluoroquinolones
5 J01MA02 Ciprofloxacin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1 g
PAREN - Parenteral 0.5 g

Active ingredients in J01MA02

Active Ingredient Description
Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Related product monographs

Title Information Source Document Type  
CIPLOX Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
CIPRO Film-coated tablet / Oral suspension kit FDA, National Drug Code (US) MPI, US: SPL/PLR
CIPROFLOXACIN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CIPROFLOXACIN Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Ciproxin Tablets 250mg Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MEDOCIPRIN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
PROFLOXIN Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
VIPROLOX Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Finland (FI)

France (FR)

Germany (DE)

Israel (IL)

Japan (JP)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.